Average peak sales forecast per new biopharmaceutical asset 2013-2023
This statistic shows the projected average peak sales per new pharmaceutical pipeline asset from 2013 to 2023, in million U.S. dollars.The projected average peak sales per new asset dropped from 555 million U.S. dollars in 2017 to 362 million U.S. dollars in 2023.